FAQs
Clinical Pharmacology services frequently asked questions
We can accept samples in a number of ways as we have the ability to extract the drug target through solid phase extraction, liquid extraction and protein precipitation. This can be discussed during the enquiry and scoping phase.
This will vary according to your method, number of samples and the MORU research programme. While we might make some tweaks to make things as efficient as possible across equipment, we schedule things on a first come, first served basis and so if we know when the samples are due to arrive we can plan this with you.
This depends on the services you require but for cost services including extraction and measurement, costs are around US$45 - US$90.
We have around 10,000 samples within our study. Do you have the capacity to do routine drug analysis on that many samples?
We can analyse around 15,000 samples per year, including MORU’s own research programmes. If you contact us with details of your proposal and timings, we will be able to review this with you.
No problem assuming you have enough sample to be processed. We can establish what is feasible during the initial consultation and work with you to make this as efficient as possible for getting your results.
We are really interested in developing new methods and welcome collaborative opportunities. Make sure you highlight this in your initial enquiry and we can discuss this during the consultation.
This is fine, you’ll just need the core services.
A run is undertaken on a 96-well plate which allows for extracting 73 samples with the remaining 23 wells used for calibration standards and quality control samples. We can do this for anything over 100 samples or more.
MORU has its own QA/QC sub-department which operates independently, holding the lab accountable through objective oversight. All assays are developed, validated and conducted in accordance with international standards and requirements of ISO 15189:2012 and ISO 15190:2003. Laboratory personnel performing specific tasks are knowledgeable, well-trained and qualified prior to work on customer samples.
The full ISO accreditation standards require that all processing is undertaken by a member of the MORU Clinical Pharmacology team. However collaborators wishing to observe are welcome upon request and will be supported where possible.
If you can’t find the information you need on these pages of the website, we are happy to assist you in providing information for grant applications and in submitting Letters of Collaboration for research scientist applying for grants intended to fund a screen. If you will need this, please advise us of your intentions well in advance of grant application deadlines. Just drop us an email.
If this project is analysed as contract analysis all results generated from this project belongs to the customer. If the project is analysed as research collaboration, raw data and analysis results belongs to both MORU Clinical Pharmacology laboratory and the customer. If this is conducted as a research collaboration both parties agree not to use the data for any other purpose than agreed unless written consent has been obtained from the other party. Disclosure of confidential information is governed by the MORU Confidentially and Nondisclosure Agreement.
Yes, we are happy to assist with this. Just drop us an email.
We can use pharmacokinetic modelling and simulation to assist with this. Just drop us an email for further discussion.
Yes, send an email to Joel Tarning, Richard Hoglund and/or Urairat